Latest Middle East News

Inghams Group delivered modest revenue growth in FY26 but saw net profit collapse amid cost pressures and tax disputes. Executive short-term incentives were forfeited, while the company declared a fully franked dividend and outlined a cautious FY27 outlook.

James Hardie Industries has agreed to divest its European Fermacell sustainable walling and flooring business to Holcim for €840 million, while planning to close its European fiber cement operations and launch a $250 million share buyback.

Servcorp Limited delivered a record FY26 with a 24% rise in underlying NPBIT to $87 million, boosted dividends by 14%, and outlined a cautious yet optimistic FY27 growth strategy.

Medical Developments International (ASX:MVP) reported a 9% revenue increase to $42.6 million and a 566% jump in net profit to $0.6 million for FY26, driven by robust growth in its Pain Management segment and expanded paediatric approvals in Europe.

Ridley Corporation’s FY26 results reveal a dramatic revenue surge fueled by its Incitec Pivot Fertilisers acquisition, alongside a significant profit drop due to a $31.8 million impairment on NovaqPro® and acquisition costs. The company declares a higher fully franked dividend, signaling confidence despite challenges.

Redox Limited reported a robust FY26 with profit after tax rising 19.2% to $91.9 million on record revenue of $1.33 billion, supported by strong North American growth and improved margins. The company declared a fully franked final dividend of 6.5 cents, bringing total dividends to 13 cents per share.

Bega Cheese Limited has delivered a robust FY2026 with a $54.8 million statutory profit, a 6.7% revenue increase, and a raised final dividend of 7.5 cents per share. The company is advancing its strategic growth plans focused on high-protein products, international expansion, and sustainability initiatives.

Super Retail Group reported a 3.2% revenue increase to $4.2 billion in FY26, but statutory net profit fell 7.2% to $206 million amid higher costs and project investments. A new five-year strategy aims to drive growth despite a challenging retail environment.

Skellerup Holdings delivered a tenth consecutive year of EBIT growth with a 14% rise to NZD 89.3 million and expanded its climate initiatives, reporting a 24% jump in net profit to NZD 67.7 million.

Recce Pharmaceuticals has secured ethics approval to add an active-controlled arm to its pivotal Phase 3 trial of RECCE® 327 Topical Gel for diabetic foot infections in Australia, enabling head-to-head comparison against existing antibiotics.

Lycopodium Limited reported a solid FY26 with $377.5 million revenue, a slight profit dip, and a 69% dividend hike, while setting sights on accelerated growth in the Americas.

Whitehaven Coal reported a 29% drop in underlying net profit to $227 million for FY26, despite record safety outcomes and successful debt refinancing that lowered funding costs and extended maturities.